Capital World Investors
AGIO icon

Capital World Investors’s Agios Pharmaceuticals AGIO Stock Holding History

Capital World Investors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-88,000
Closed -$4.06M – 527
2018
Q4 		$4.06M Hold
88,000
– – ﹤0.01% 500
2018
Q3 		$6.79M Sell
88,000
-332,000
-79% -$26.7M ﹤0.01% 522
2018
Q2 		$35.4M Hold
420,000
– – 0.01% 400
2018
Q1 		$34.3M Sell
420,000
-243,000
-37% -$18.8M 0.01% 384
2017
Q4 		$37.9M Hold
663,000
– – 0.01% 377
2017
Q3 		$44.3M Hold
663,000
– – 0.01% 363
2017
Q2 		$34.1M Hold
663,000
– – 0.01% 375
2017
Q1 		$38.7M Hold
663,000
– – 0.01% 370
2016
Q4 		$27.7M Hold
663,000
– – 0.01% 374
2016
Q3 		$35M Sell
663,000
-1,413,491
-68% -$61.6M 0.01% 363
2016
Q2 		$87M Sell
2,076,491
-1,059,629
-34% -$52.3M 0.02% 292
2016
Q1 		$127M Hold
3,136,120
– – 0.04% 253
2015
Q4 		$204M Buy
3,136,120
+105,000
+3% +$6.89M 0.06% 226
2015
Q3 		$214M Sell
3,031,120
-140,000
-4% -$13.7M 0.06% 227
2015
Q2 		$352M Buy
3,171,120
+14,000
+0.4% +$1.51M 0.1% 194
2015
Q1 		$298M Buy
3,157,120
+58,123
+2% +$6.51M 0.08% 206
2014
Q4 		$347M Buy
3,098,997
+1,966,877
+174% +$176M 0.09% 193
2014
Q3 		$69.5M Hold
1,132,120
– – 0.02% 337
2014
Q2 		$51.9M Buy
1,132,120
+797,120
+238% +$32.5M 0.01% 355
2014
Q1 		$13.1M Buy
335,000
+191,300
+133% +$6.4M ﹤0.01% 451
2013
Q4 		$3.44M Buy
143,700
+73,700
+105% +$1.68M ﹤0.01% 477
2013
Q3 		$1.96M Buy
+70,000
New +$1.93M ﹤0.01% 471

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Capital World Investors's AGIO Position: Q1 2019 in Review

Capital World Investors sold out of Agios Pharmaceuticals (AGIO) in Q1 2019, closing a stake of 88,000 shares — an estimated $4.06M sold.

Capital World Investors first reported a position in AGIO in Q3 2013 and held it in 22 quarters. The position peaked at $352M in Q2 2015. 201 funds tracked by Wall St. Rank hold AGIO as of Q1 2019.

  • Capital World Investors reported no remaining Agios Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Capital World Investors sold 88,000 Agios Pharmaceuticals shares in Q1 2019, an estimated $4.06M.
  • Capital World Investors first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 22 quarters.
  • Capital World Investors's Agios Pharmaceuticals position peaked at $352M in Q2 2015.
  • 201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2019.

Based on Capital World Investors's 13F filing for Q1 2019, filed 15 May 2019.